慢性阻塞性肺病的生物疗法:随机对照试验的系统审查和网络元分析
Tyler Pitre1,2, Daniel Lupas3, Jasmine Mah4
1Division of Respirology, Department of Medicine, University of Toronto, Toronto, ON, Canada.
COPD
|January 29, 2025
概括
杜皮卢马布有效地减少了COPD患者的恶化,特别是那些高氨基细胞患者. 在本系统性审查中,其他生物药物对患者相关结果的影响有限.
科学领域:
- 肺部医学 肺部医学
- 药理学 药理学是指药理学的学科.
- 临床试验 临床试验
背景情况:
- 对于慢性阻塞性肺部疾病 (COPD) 存在有限的药物治疗突破.
- 最近的试验表明,生物疗法对COPD患者有潜在的益处.
- 目前还没有全面综合COPD中生物药物的证据.
研究的目的:
- 系统地审查和对COPD患者生物药物的随机对照试验进行元分析.
- 评估生物药物对恶化,FEV1,生活质量和不良事件的疗效.
- 使用GRADE框架评估证据的确定性.
主要方法:
- 在 MEDLINE,EMBASE 和 Cochrane CENTRAL 的系统文献搜索,截至 2024 年 7 月 17 日.
- 随机效应频率主义者网络元分析以比较生物治疗.
- 格雷德框架用于评估所有结果的证据确定性.
主要成果:
- 与安慰剂相比,dupilumab显著减少了恶化 (高度确定性).
- 在患有高血红蛋白细胞 (≥300/mcL) 的患者中,Tezepelumab和dupilumab显示了FEV1在MCID以上的可能改善.
- 在所有COPD患者中,没有生物疗法显示出FEV1在临床上有意义的改善.
结论:
- 杜皮卢马布在改善COPD患者的患者相关结果方面表现出有效性,COPD患者具有高氨基酸细胞计数.
- 在本分析中,其他生物疗法,如tzepelumab,对患者相关的结局没有显著影响.
- 生物疗法,特别是dupilumab,代表了管理特定COPD患者亚组的有希望的途径.
更多相关视频
05:19Author Spotlight: An Effective Traditional Chinese Medicinal Treatment for Chronic Obstructive Pulmonary Disease with Abdominal Distension
Published on: September 1, 2023
1.4K
05:34Author Spotlight: Utilizing Traditional Chinese Acupuncture of the Ear to Improve Sleep Disorders
Published on: August 18, 2023
2.1K
相关概念视频
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
01:26COPD: Management Using Bronchodilators and Corticosteroids
186
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
186
01:22Chronic Obstructive Pulmonary Disease
1.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.2K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
01:17Drugs Used in Lower Respiratory Disorders: Overview
360
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
360
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K